Eli Lilly & Company will pay up to $325 million to Amylin Pharmaceuticals, a biotechnology company based in San Diego, for the rights to a potentially promising treatment for diabetes.
Read More »Issue 124 Item 2 High Cholesterol Can Predict Childhood Obesity
Although conventional wisdom is that obesity causes high cholesterol, results of a study in the September issue of the American Journal of Clinical Nutrition suggest that, at least for girls, high cholesterol can be a marker of obesity developing later in childhood.
Read More »Issue 125 Item 2 Repaglinide Versus Metformin in Combination With Bedtime NPH
Combined with bedtime NPH insulin, metformin provides superior glycemic control to repaglinide.
Read More »Issue 126 Item 2 Acidic Drinking Water May Increase Risk of Type 1 Diabetes
Low pH drinking water in individual households is strongly associated with the risk of type 1 diabetes, according to results of a study reported in the September issue of Diabetes Care.
Read More »Issue 121 Item 1 80 Percent of Patients Remain Insulin-Free One Year After Islet
One-year, insulin-free status also was achieved in a child who received a mixture of pig islet cells, without the use of immunosuppressive drugs.
Read More »Issue 122 Item 1 Plant Protein No Better Than Animal Protein For Type 2 Diabetic
A diet that derives protein from plant sources only has no advantage over a diet that contains animal protein for individuals with type 2 diabetes and microalbuminuria, researchers report.
Read More »FDA Approves Avapro (Irbesartan) For The Treatment Of Diabetic
When patients with diabetes and kidney disease were treated with Avapro the risk of progression of their nephropathy or death was 20 percent lower.
Read More »Issue 124 Item 1 Experts Reach Consensus on Causes of Type 2 Diabetes
Genetics, fetal origins, lifestyle and stress may all be risk factors of Type 2 diabetes
Read More »Issue 125 Item 1 Soy and HRT Improves Risk Factors for Heart Disease in Women wi
Patients with diabetes taking soy had improved control of blood-sugar levels and a significant drop in LDL or “bad” cholesterol and insulin resistance, suggesting a reduced risk of heart disease
Read More »Issue 126 Item 1 1 in 4 Type 2 Diabetes Patients Have Heart Disease With No Symp
New screening tool can identify “silent coronary artery disease at an early stage in patients with diabetes
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.